Rebif® For Early Symptoms Of Multiple Sclerosis, UK

Rebif® (interferon beta-1a), a disease-modifying medication used to treat relapsing forms of multiple Sclerosis (MS), is now available in the UK to treat individuals with clinically isolated syndrome (CIS), a potential early indicator of MS, announced Merck Serono, a division of Merck KGaA, Darmstadt, Germany…

More: continued here

Filed under: Multiple Sclerosis on January 26th, 2012